WorldQuant Millennium Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $305M | Buy |
331,823
+102,703
| +45% | +$104M | 1.18% | 11 |
|
|
2025
Q4 | $246M | Buy |
229,120
+68,283
| +42% | +$65.3M | 0.96% | 17 |
|
|
2025
Q3 | $123M | Buy |
160,837
+68,037
| +73% | +$50.6M | 0.53% | 54 |
|
|
2025
Q2 | $72.3M | Sell |
92,800
-25,465
| -22% | -$19.8M | 0.36% | 72 |
|
|
2025
Q1 | $97.7M | Sell |
118,265
-12,645
| -10% | -$10.5M | 0.62% | 43 |
|
|
2024
Q4 | $101M | Sell |
130,910
-59,590
| -31% | -$49.3M | 0.65% | 29 |
|
|
2024
Q3 | $169M | Buy |
190,500
+172,832
| +978% | +$155M | 1.23% | 13 |
|
|
2024
Q2 | $16M | Sell |
17,668
-41,860
| -70% | -$33.5M | 0.15% | 172 |
|
|
2024
Q1 | $46.3M | Buy |
59,528
+13,979
| +31% | +$9.95M | 0.57% | 46 |
|
|
2023
Q4 | $26.6M | Sell |
45,549
-52,428
| -54% | -$30.6M | 0.37% | 79 |
|
|
2023
Q3 | $52.6M | Buy |
97,977
+87,434
| +829% | +$45.1M | 0.81% | 23 |
|
|
2023
Q2 | $4.94M | Sell |
10,543
-87,692
| -89% | -$36.8M | 0.08% | 242 |
|
|
2023
Q1 | $33.7M | Buy |
98,235
+26,078
| +36% | +$8.8M | 0.62% | 46 |
|
|
2022
Q4 | $26.4M | Buy |
72,157
+39,167
| +119% | +$13.9M | 0.6% | 47 |
|
|
2022
Q3 | $10.7M | Sell |
32,990
-62,241
| -65% | -$19.7M | 0.26% | 122 |
|
|
2022
Q2 | $30.9M | Buy |
95,231
+30,371
| +47% | +$9.12M | 0.88% | 22 |
|
|
2022
Q1 | $18.6M | Buy |
64,860
+55,421
| +587% | +$14.3M | 0.45% | 69 |
|
|
2021
Q4 | $2.61M | Sell |
9,439
-69,602
| -88% | -$17.6M | 0.05% | 256 |
|
|
2021
Q3 | $18.3M | Buy |
+79,041
| New | +$19.5M | 0.4% | 81 |
|
|
2021
Q1 | – | Sell |
-105,343
| Closed | -$17.8M | – | 354 |
|
|
2020
Q4 | $17.8M | Hold |
105,343
| – | – | 0.39% | 83 |
|
|
2020
Q3 | $15.6M | Buy |
105,343
+807
| +0.8% | +$125K | 0.37% | 85 |
|
|
2020
Q2 | $17.2M | Buy |
104,536
+60,438
| +137% | +$9.28M | 0.4% | 82 |
|
|
2020
Q1 | $6.12M | Sell |
44,098
-3,896
| -8% | -$535K | 0.15% | 182 |
|
|
2019
Q4 | $6.31M | Sell |
47,994
-6,049
| -11% | -$701K | 0.12% | 204 |
|
|
2019
Q3 | $6.04M | Buy |
54,043
+50,581
| +1,461% | +$5.63M | 0.12% | 196 |
|
|
2019
Q2 | $384K | Sell |
3,462
-4,460
| -56% | -$525K | 0.01% | 288 |
|
|
2019
Q1 | $1.03M | Sell |
7,922
-135,580
| -94% | -$16.5M | 0.02% | 255 |
|
|
2018
Q4 | $16.6M | Buy |
143,502
+34,258
| +31% | +$3.83M | 0.49% | 74 |
|
|
2018
Q3 | $11.7M | Buy |
109,244
+4,249
| +4% | +$425K | 0.39% | 99 |
|
|
2018
Q2 | $8.96M | Buy |
+104,995
| New | +$8.62M | 0.34% | 104 |
|
Other funds holding LLY
VCM
VPM
WorldQuant Millennium Advisors's LLY Position: Q1 2026 in Review
WorldQuant Millennium Advisors increased its Eli Lilly (LLY) stake by 45% in Q1 2026, buying an estimated $104M and bringing the position to 331,823 shares worth $305M. The position accounts for 1.18% of the portfolio, ranked #11.
WorldQuant Millennium Advisors first reported a position in LLY in Q2 2018 and has held it in 30 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- WorldQuant Millennium Advisors held 331,823 shares of Eli Lilly worth $305M as of Q1 2026.
- WorldQuant Millennium Advisors bought 102,703 Eli Lilly shares in Q1 2026, an estimated $104M.
- Eli Lilly made up 1.18% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #11 holding.
- WorldQuant Millennium Advisors first reported a position in Eli Lilly in Q2 2018 and has held it in 30 quarters since.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.